Track topics on Twitter Track topics that are important to you
The India-based manufacturer receives a Form 483 from the US FDA after the agency noted the company failed to thoroughly review discrepancies.
Original Article: Sun Pharma receives Form 483 due to out-of-spec productsNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...